← All trials
NCT02228382
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 7, 2014
- Primary completion
- Jul 30, 2021
- Completion date
- Jul 30, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 165
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- PfizerLead sponsor
- PfizerStudy director
- Developmental Therapeutics ConsortiumCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.